Retinal vascular events after intravitreal bevacizumab.

Purpose: To record retinal vascular events following intravitreal bevacizumab injection.

Methods: Collaborative multi-centre retrospective case series.

Results: Eight patients were documented to have central retinal artery occlusion (four patients), branch retinal artery occlusion, capillary occlusion, central retinal vein occlusion and branch retinal vein occlusion (one patient each) within 0-55 days (median 2 weeks) of intravitreal bevacizumab.